Quick Search 
Drugs of Today
Register or sign in

Volume 56, Issue 2, February 2020, Pages 109-172
 Doravirine: a new non-nucleoside reverse transcriptase inhibitor for the treatment of HIV infection.
Talwani, R., Temesgen, Z.
Drugs Today 2020, 56(2): 113
Summary | Full Text: PDF 
 Istradefylline: adenosine A2A receptor antagonist to reduce “OFF” time in Parkinson's disease.
Paton, D.M.
Drugs Today 2020, 56(2): 125
Summary | Full Text: PDF 
 Mirogabalin besylate in the treatment of neuropathic pain.
Burgess, J., Javed, S., Frank, B., Malik, R.A., Alam, U.
Drugs Today 2020, 56(2): 135
Summary | Full Text: PDF 
 JAK inhibitors in chronic plaque psoriasis: What is known so far.
Plachouri, K.-M., Georgiou, S.
Drugs Today 2020, 56(2): 151
Summary | Full Text: PDF 
 Medicines for Europe – 13th Pharmacovigilance Conference (January 29, 2020 – Amsterdam, the Netherlands).
Hamaui Cuadrado, S.
Drugs Today 2020, 56(2): 165
Summary | Full Text: PDF 
 New product intros [avapritinib, benzhydrocodone hydrochloride/acetaminophen (new combination), crizanlizumab-tmca (first-in-class), enfortumab vedotin-ejfv (first-in-class), givosiran (first-in-class), lasmiditan succinate (first-in-class), semaglutide (new indication), ubrogepant].
Drugs Today 2020, 56(2): 169
Full Text: PDF 

© 2020 Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy